MSFKX
Price
$19.65
Change
-$0.04 (-0.20%)
Updated
Aug 6 closing price
Net Assets
7.64B
RLBCX
Price
$36.81
Change
+$0.10 (+0.27%)
Updated
Aug 6 closing price
Net Assets
252.49B
Interact to see
Advertisement

MSFKX vs RLBCX

Header iconMSFKX vs RLBCX Comparison
Open Charts MSFKX vs RLBCXBanner chart's image
MFS Total Return R6
Price$19.65
Change-$0.04 (-0.20%)
VolumeN/A
Net Assets7.64B
American Funds American Balanced R3
Price$36.81
Change+$0.10 (+0.27%)
VolumeN/A
Net Assets252.49B
MSFKX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MSFKX vs. RLBCX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSFKX is a Hold and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 252B vs. MSFKX (7.64B). MSFKX pays higher dividends than RLBCX: MSFKX (2.63) vs RLBCX (1.56). MSFKX was incepted earlier than RLBCX: MSFKX (13 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than MSFKX (0.40). MSFKX is a more actively managed with annual turnover of: 53.00 vs. RLBCX (44.00). MSFKX has a lower initial minimum investment than RLBCX: MSFKX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 10.44 vs. MSFKX (2.24). RLBCX return over 5 years is better than : 34.86 vs. MSFKX (11.54).
MSFKXRLBCXMSFKX / RLBCX
Total Expense Ratio0.400.8945%
Annual Report Gross Expense Ratio0.400.8945%
Fund Existence13 years23 years-
Gain YTD5.8738.41870%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets7.64B252B3%
Annual Yield % from dividends2.631.56169%
Returns for 1 year2.2410.4421%
Returns for 3 years10.2730.1734%
Returns for 5 years11.5434.8633%
Returns for 10 years36.9361.8460%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRN148.3220.09
+15.67%
Stride
CFG46.93-0.37
-0.78%
Citizens Financial Group
CMPS4.36-0.12
-2.68%
COMPASS Pathways Plc
CNTB2.13-0.07
-3.18%
Connect Biopharma Holdings Limited
APRE1.64-0.15
-8.38%
Aprea Therapeutics